Sun Pharma to Scale Up API Production, Proposes $30 Million Investment in Gujarat Plant, an Industrial Info Market Brief

Indian pharma-major Sun Pharma Industries Limited plans to invest nearly $30 million to increase production of high-potency active pharmaceutical ingredients (API) at its plant in Gujarat state on the western coast of India. Sun Pharma currently produces about 300 APIs and plans to scale up its capacity by adding 20 new APIs annually to its product portfolio. Industrial Info is tracking developments at 23 Sun Pharma plants globally. Industrial Info's database has 1,881 API manufacturing plant records with 8,479 functional management contacts.